Form 4: Medpace Holdings Director Acquires Stock Options

Director Femida H. Gwadry-Sridhar acquired stock options in Medpace Holdings, Inc. on May 16, 2025.

Summary

• Femida H. Gwadry-Sridhar, a director of Medpace Holdings, Inc., filed a Form 4 to report changes in beneficial ownership.
• On May 16, 2025, Gwadry-Sridhar acquired 1,224 stock options with an exercise price of $305.66.
• The options vest on the earlier of the day before the first annual meeting following the grant date or the first anniversary of the grant date, contingent upon continued service on the board.
• Following the transaction, Gwadry-Sridhar directly owns 1,224 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard stock option grant to a director. It doesn't inherently indicate positive or negative performance.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Medpace Holdings, Form 4, stock options, beneficial ownership, director, MEDP, Gwadry-Sridhar, acquisition